Kocaeli University   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Kocaeli Turkey (1976)

Organization Overview

First Clinical Trial
2007
NCT01831310
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Bosnalijek D.D | Emine Dundar Ahi | Kocaeli Derince Education and Research Hospital | Kocaeli University | Kocaeli University, Faculty of Medicine | Kocaeli University Faculty of Medicine Cardiology Dept | Kocaeli University, Faculty of Medicine, Emergency Department | Kocaeli University School of Medicine | Neslihan Tekçe

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Aggression (Phase 4)

Aggressive Periodontitis (Phase 4)

Cerebral Palsy (Phase 3)

Colic (Phase 4)

Colorectal Neoplasms (Phase 4)

Communicable Diseases (Phase 3)

Congenital Abnormalities (Phase 3)

Dizziness (Phase 4)

Eclampsia (Phase 4)

Emergencies (Phase 4)

Endometriosis (Phase 4)

Gastroenteritis (Phase 4)

Gastrointestinal Hemorrhage (Phase 4)

Heart Failure (Phase 4)

Hemorrhage (Phase 4)

Infections (Phase 3)

Malnutrition (Phase 4)

Metabolic Syndrome (Phase 4)

Migraine Disorders (Phase 4)

Multiple Sclerosis (Phase 3)

Multiple Sclerosis, Relapsing-Remitting (Phase 3)

Paralysis (Phase 3)

Periodontitis (Phase 4)

Pharyngitis (Phase 3)

Pre-Eclampsia (Phase 4)

Sclerosis (Phase 3)

Syndrome (Phase 4)

Urinary Bladder, Overactive (Phase 4)

Vertigo (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 30
  • # of Trial APIs: 37